Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Morgane C Mouslim"'
Publikováno v:
Expert Opinion on Biological Therapy. 22:679-688
Globally, biosimilars are expected to play a key role in lowering healthcare costs and providing increased patient access to biological therapies. Given this, and in line with the European Union and World Health Organization, many emerging nations ha
Publikováno v:
The American journal of managed care. 28(11)
To describe the uptake and out-of-pocket (OOP) costs of Basaglar, the first long-acting insulin biosimilar, in a commercially insured population in the United States.Retrospective analysis of commercial pharmacy claims and pharmacy co-payment offsets
Autor:
Jenny S. Guadamuz, Jocelyn Wilder, Morgane C Mouslim, Shannon N. Zenk, Dima M. Qato, G. Caleb Alexander
Publikováno v:
Health Affairs. 40:802-811
The accessibility of pharmacies may be an overlooked contributor to persistent racial and ethnic disparities in the use of prescription medications and essential health care services within urban areas in the US. We examined the availability and geog
Hospital And Regional Characteristics Associated With Emergency Department Facility Fee Cash Pricing
Publikováno v:
Health affairs (Project Hope). 41(7)
Self-pay patients are an understudied yet important and financially vulnerable population of emergency department (ED) users. As ED facility fees may be a key cost driver in patient ED bills, we leveraged newly available hospital pricing data to desc
Publikováno v:
Value Health
Objectives To estimate the effect of filgrastim-sndz market entry on patient out-of-pocket costs and claim payments for filgrastim products. Methods This study used a single interrupted time series design with longitudinal, nationally representative,
Autor:
Sally B. Coburn, Kathryn Foti, Morgane C. Mouslim, Lorraine T. Dean, Jowanna Malone, Laura Camarata, Mingyu Zhang, Katherine Robsky, Neia Prata Menezes, Kathryn M. Leifheit, Maneet Kaur, Amelia S Wallace, Ebony A Moore, Keri N. Althoff, Frances S Burman, Aisha S. Dickerson, Brooke A. Jarrett, Olive Tang
Publikováno v:
Am J Epidemiol
Increasing diverse engagement in the Society for Epidemiologic Research (SER) will positively impact the field of epidemiology. As the largest and longest-running epidemiologic society in North America, SER has long been a pioneer in promoting divers
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To identify and synthesize the literature on healthcare system distrust across the breast cancer continuum of care METHODS: We searched CINAHL, Cochrane, EMBASE, PubMed, PsycINFO, and Web of Science from January 1(st), 1990 to December 31(st
Autor:
Chenguang Wang, Morgane C. Mouslim, Karen L. Smith, Neha Mangini, Vered Stearns, Elaine Chiao, David Lim, Kimberley T. Lee
Publikováno v:
Journal of Clinical Oncology. 39:1016-1016
1016 Background: CDK4/6i improve survival outcomes for first-line treatment of patients with hormone receptor positive (HR+), human epidermal growth factor-2 negative (HER2-) MBC. Yet, not all eligible patients (pts) receive a first-line CDK4/6i. We
Publikováno v:
JAMA Intern Med
Importance Biosimilar biologic products were authorized in 2010, after the US Congress established an expedited pathway for approval of clinically similar versions of approved biologic products. Unlike for most small-molecule generic drugs, approval
Autor:
Henderson MA; Morgan A. Henderson, University of Maryland, Baltimore County, Baltimore, Maryland., Mouslim MC; Morgane C. Mouslim (mmousli1@umbc.edu), University of Maryland, Baltimore County.
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2022 Jul; Vol. 41 (7), pp. 1029-1035.